Advanced search
Publication Cover
International Journal of Neuroscience Volume 131, 2021 - Issue 9
Submit an article Journal homepage
195
Views
7
CrossRef citations to date
0
Altmetric
Original Articles

The correlation of neutrophil-to-lymphocyte ratio with the presence and short-time curative effect of myasthenia gravis in children: a retrospectively study

Zhi Jianga Department of Neurology, Hunan Children’s Hospital, Changsha, ChinaCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-9390-3342
ORCID Icon,
Zeshu Ninga Department of Neurology, Hunan Children’s Hospital, Changsha, China
,
Liming Yanga Department of Neurology, Hunan Children’s Hospital, Changsha, China
,
Bo Chena Department of Neurology, Hunan Children’s Hospital, Changsha, China
,
Jingwen Tanga Department of Neurology, Hunan Children’s Hospital, Changsha, China
,
Jie Zhanga Department of Neurology, Hunan Children’s Hospital, Changsha, China
,
Hongjun Fanga Department of Neurology, Hunan Children’s Hospital, Changsha, China
,
Rong Xua Department of Neurology, Hunan Children’s Hospital, Changsha, China
,
Feng Guoa Department of Neurology, Hunan Children’s Hospital, Changsha, China
,
Mei Chena Department of Neurology, Hunan Children’s Hospital, Changsha, China
&
Kaisheng Sunb Institute of Pediatric Medicine, Hunan Children’s Hospital, Changsha, China
 show all
Pages 894-901 | Received 25 Dec 2019, Accepted 11 Apr 2020, Published online: 30 Apr 2020

References

  • Barraud C, Desguerr I, Barnerias C, et al. Clinical features and evolution of juvenile myasthenia gravis in a French cohort. MuscleNerve. 2018;57:603–609.
  • Huang S, Wang W, Chi L. Feasibility of up-regulating CD4 + CD25+ Tregs by IFN-Υ in myasthenia gravis patients. BMC Neurol. 2015;15(1):163.
  • Molin CJ, Westerberg E, Punga AR. Profile of upregulated inflammatory proteins in sera of myasthenia gravis patients. Sci Rep. 2017;7:39716.
  • Uzawa A, Kanai T, Kawaguchi N, et al. Changes in inflammatorycytokine networks in myasthenia gravis. Sci Rep. 2016;6(1):25886–258990.
  • Luo J, Lindstrom J. AChR-specific immunosuppressive therapy of myasthenia gravis. Bioochem Pharmacol. 2015;97(4):609–619.
  • Jing F, Yang F, Cui F, et al. Rapamycin alleviates inflammation and muscle weakness, while altering the Treg/Th17 balance in a rat model of myasthenia gravis. Biosci Rep. 2017;37(4):1–10.
  • Shahgah AG, Fattahi E, Shahneh FZ. Interleukin-17 in human inflammatory disease. Postepy Dermatol Altrgol. 2014;31(4):256–261.
  • Chen G, Zhu L, Yang Y, et al. Prognostic role of neutrophil-to-lymphocyte ratio inovarian cancer: a meta-analysis. Technol Cancer Treatment. 2018;1:17.
  • Kaushik R, Gupta M, Sharma M, et al. Diagnostic and prognostic role of neutrophil-to-lymphocyte ratio in early and late phase of sepsis. Indian J Crit Care Med. 2018;22(9):660–663.
  • Yang DH, Qian MZ, Wei MM, et al. The correlation of neutrophil-to-lymphocyte ratio with the presence and activity of myasthenia gravis. Oncotarget. 2017;8(44):76099–76107.
  • Jaretzki A, 3rd, Barohn RJ, Ernstoff RM, Kaminski HJ, et al. Myasthenia gravis：recommendations for clinical research standards. Task Force of the Medical Scientific Adisory Board of the Myasthenia GravisFoundation of America. Ann Thorac Surg. 2000;70(1):327–334.
  • Yang D, Weng Y, Lin H, et al. Serum uric levels in patients with myasthenia gravis are inversely correlated wirh disability. NeuroReport. 2016;27(5):301–305.
  • Uzawa A, Kawaguchi N, Kanai T, et al. Increased ser-um peroxiredoxin 5 levels in myasthenia gravis. J Neuroimmunol. 2015;287:16–18.
  • Uzawa A, Kawaguchi N, Kanai T, et al. Serum high mobilitygroup box 1 is upregulated in myasthenia gravis. J Neurol Neurosurg Psychiatry. 2015;86(6):695–697.
  • Gihus NE, Verschuuren JJ. Myasthenia gravis: subgroup classification and therapeutic strategies. Lancet Neurol. 2015;14:1023–1036.
  • Uzawa A, Kawaguchi N, Himuro K, et al. Serum cytokine and chemokine profiles in patients with myasthenia gravis. Clin Exp Immunol. 2014;176(2):232–237.
  • Weng YY, Yang DH, Qian MZ, Wei MM, et al. Low serum albumin concentrations are associated with disease severity in patients with myasthenia gravis. Medicine. 2016;95:39–44.
  • Lee YS, Nam HS, Lim JH, et al. Prognostic impact of a new score using neutrophil-to-lymphocyte ratios in the serum and malignant pleural effusion in lung cancer. BMC Cancer. 2017;17(1):557.
  • Zhang Y, Lu JJ, Du YP, et al. Prognostic value of ne-utrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in gastric cancer. Medicine. 2018;97:12.
  • Guan YZ, Gui LY, Li YF, et al. Tumor necrosis factor-α polymorphism and secretion in myasthenia gravis. Clin Med Sci. 2005;20(2):104–107.
  • Lee JS, Joo IS, Seok JI. Widely varying TNF-alpha levels in patients with myasthenia gravis. Neurol Sci. 2009;30(3):259–262.
  • Aricha R, Mizrachi K, Fuchs S, et al. Blocking of IL-6 suppresses experimental autoimmune myasthenia gravis. J Autoimmun. 2011;36(2):135–141.
  • Cao Y, Amezquita RA, Kleinstein SH, et al. Autoreative T cells from patients with myasthenia gravis are characterized by elevated IL-17, IFN-Y, and GM-CSF and diminished IL-10 production. JI. 2016;196(5):2075–2084.
  • Kusner LL, Kaminski HJ. The role of complement in experimental autoimm-une myasthenia gravis. Ann N Y Acad Sci. 2012;1274(1):127–132.
  • Truffault F, de Montpreville V, Eymard BS, et al. Thymic germinal centers and corticosteroids in myasthenia gravis：an immunopathological study in 1035 cases and a critical review. Clinic Rev Allerg Immunol. 2017;52(1):108–124.
  • Cavalcante P, Cufi P, Mantegazza R, et al. Etiology of myasthenia gravis: innate immunity signature in pathological thymus. Autoimmun Rev. 2013;12(9):863–874.
  • Fuhua P, Xuhui D, Zhiyang Z, et al. Antioxidiant status of bilirubin and uric acid in Patient with myasthenia gravis. Neuroimmunomodulation. 2012;19(1):43–49.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.